Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2018 Jan 7;6(1):76-78.
doi: 10.3889/oamjms.2018.039. eCollection 2018 Jan 25.

A "Yellow Submarine" in Dermoscopy

Affiliations
Case Reports

A "Yellow Submarine" in Dermoscopy

Francesca Satolli et al. Open Access Maced J Med Sci. .

Abstract

Background: Histiocytic sarcoma (HS) is an extremely rare, non-Langerhans cell tumor. HS affects especially adults, its etiology is unknown yet. Skin could be interested by papules or nodules, single or multiple.

Case report: A Caucasian man in his late 40s came to our clinic for a naevi evaluation. During the visit, a rose papulonodular lesion was observed in the lumbar region. This lesion was completely asymptomatic, and it had been there for an indefinite period. The clinical evaluation revealed that the lesion appeared elevated, of 9 x 15 mm in dimension, symmetrical and of a homogeneous pinkish colour. The videodermoscopical evaluation revealed a homogeneous yellow central pattern, polymorphic vessels, an eccentric peripheral pigmentation and a white collar. An excisional biopsy was performed. The morphology and the expression of CD163, CD68 and/or lysozyme to the immunophenotypic analysis, revealed the true nature of the lesion.

Conclusion: HS is usually diagnosed at an already advanced clinical stage and it has a high mortality rate even today. Dermoscopy, showing a yellow and distributed homogeneously colour, can facilitate its hard diagnosis.

Keywords: CD68; WHO classification lymphomas; dermoscopy; histiocytic sarcoma; yellow colour.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Clinical evaluation (A, B)
Figure 2
Figure 2
Dermoscopic evaluation
Figure 3
Figure 3
Morphology
Figure 4
Figure 4
Immunophenotype (first line, from left to right: CD4, CD68; second line, from left to right: CD163, Ki67). [Courtesy of Dr Mancini C., Unità Operativa di Anatomia e Istologia Patologica, Dipartimento Diagnostico, Università degli Studi di Parma]

References

    1. Takahashi E, Nakamura S. Histiocytic Sarcoma:An Updated Literature Review Based on 2008 WHO classification. J Clin Exp Hematop. 2013;53(1) https://doi.org/10.3960/jslrt.53.1. - PubMed
    1. Ansari J, Nagash AR, Munker R, et al. Histiocytic sarcoma as a secondary malignancy:photobiology, diagnosis, and treatment. Eur J Haematol. 2016;97(1):9–16. https://doi.org/10.1111/ejh.12755 PMid:26990812. - PubMed
    1. Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of the Haematopoietic and Lymphoid Tissues. IARC. 2008;4:270–319.
    1. Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127:2375–2390. https://doi.org/10.1182/blood-2016-01-643569 PMid:26980727 PMCid:PMC4874220. - PMC - PubMed
    1. Cavicchini S, Tourlaki A, Bottini, et al. Dermoscopy of Solitary Yellow Lesions in Adults. Arch Dermatol. 2008;144(10):1412. https://doi.org/10.1001/archderm.144.10.1412 PMid:18936419. - PubMed

Publication types

LinkOut - more resources